Effects of Mild to Severe Hepatic Impairment on the Pharmacokinetics of Sonidegib: A Multicenter, Open-Label, Parallel-Group Study

Overview of attention for article published in Clinical Pharmacokinetics, June 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,247 followers.

RT @GrupoPKgen_SEFH: No dose adjustment of #Sonidegib in patients with mild, moderate or severe hepatic impairment https://t.co/oQv39XdeQY

Reply Repost Favourite

RT @GrupoPKgen_SEFH: No dose adjustment of #Sonidegib in patients with mild, moderate or severe hepatic impairment https://t.co/oQv39XdeQY

Reply Repost Favourite

RT @GrupoPKgen_SEFH: No dose adjustment of #Sonidegib in patients with mild, moderate or severe hepatic impairment https://t.co/oQv39XdeQY

Reply Repost Favourite

No dose adjustment of #Sonidegib in patients with mild, moderate or severe hepatic impairment https://t.co/oQv39XdeQY

Reply Repost Favourite